Speech-Language Pathologists in Columbia, MO Accepting Medicare

135 Speech-Language Pathologists found. Showing 61 - 80

Erin Elaine Mccurry Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3400

Dr. Teresa Elaine Lever, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Hitt St, Columbia, MO 65212 Phone: 573-882-7903    Fax: 573-884-4607

Lora Hinkel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3000

Sandhya Sharma Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3400

Laura Kessel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3000

Jamie Barbarick Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3000

Stacey Kueny, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 525 N Keene St, Suite 101, Columbia, MO 65201 Phone: 573-882-7350

Jon L Deal, PH.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: University Of Missouri Health Care, 1 Hospital Drive (dc009.00), Columbia, MO 65212 Phone: 573-882-8706

Ms. Kerri Lynne Weber, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3702 W Broadway Apt 2209, Columbia, MO 65203 Phone: 618-559-9942

Mrs. Paige Michaela Strong, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4200 Merchant St Ste 103, Columbia, MO 65203 Phone: 157-777-8783

Mrs. Heather A Peterson, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3324 Keenes Edge Dr, Columbia, MO 65201 Phone: 573-442-0925

Morgan Keller Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3400

Claire Willard Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3000

Debra Leigh Heifner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3570

Stephanie Frank, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2333 Chapel Hill Rd, Columbia, MO 65203 Phone: 573-304-4514

Mrs. Hannah Dean Evans Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4200 Merchant St Ste 103, Columbia, MO 65203 Phone: 573-777-8783

Mallory Sims Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3700 Woodland Dr, Columbia, MO 65202 Phone: 573-301-8488

Christi S Baker, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1601 E Broadway, Box 33, Columbia, MO 65201 Phone: 573-815-3868    Fax: 573-815-2605

Mrs. Christina Elizabeth Grotewiel, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3800 Mamba Dr, Columbia, MO 65202 Phone: 660-351-1138

Mrs. Ashleigh Ohmes Boyd, MHS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 Portland St, Columbia, MO 65201 Phone: 573-884-5596    Fax: 573-884-1151

News Archive

Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.

Neurocrine Biosciences to sell 4,784,689 shares of common stock to Venrock affiliates

Neurocrine Biosciences, Inc. today reported that it has entered into a privately negotiated transaction to sell an aggregate of 4,784,689 primary shares of its common stock to affiliates of Venrock at a price of $2.09 per share, raising aggregate gross proceeds to Neurocrine of approximately $10 million. Neurocrine expects the financing to close on or about December 22, 2009, subject to customary closing conditions.

Research findings point toward new therapeutic target for aggressive breast cancer

One of the first-known oncogenes has a protein partner that helps breast cancer proliferate and when it's blocked, so is the cancer, scientists report.

Immunomedics third-quarter revenues increase to $10.7 million

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported financial results for the third quarter ended March 31, 2010. The Company also highlighted recent key developments and planned activities for its clinical pipeline.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7